Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK8 | P45983 | 1/20 | 0.76 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.76 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.76 |
| ▸ | CALCR | P30988 | 4/20 | 0.63 |
| ▸ | KEAP1 | Q14145 | 2/20 | 0.61 |
| ▸ | NPY2R | P49146 | 7/20 | 0.59 |
| ▸ | NPY4R | P50391 | 7/20 | 0.59 |
| ▸ | NPY5R | Q15761 | 7/20 | 0.59 |
| ▸ | NPY1R | P25929 | 5/20 | 0.59 |
| ▸ | KDM1A | O60341 | 1/20 | 0.57 |
| ▸ | GLP1R | P43220 | 2/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31182520 | 0.91 | KDM1A (0.67) | MAPK8MAPK9MAPK10CALCRNPY2R | |
| SCHEMBL29382839 | 0.90 | CALCR (0.65) | MAPK8MAPK9MAPK10CALCRKEAP1 | |
| SCHEMBL30887555 | 0.89 | CALCR (0.66) | MAPK8MAPK9MAPK10CALCRKEAP1 | |
| SCHEMBL30466120 | 0.89 | CALCR (0.70) | MAPK8MAPK9MAPK10CALCRGLP1R | |
| SCHEMBL30887977 | 0.88 | CALCR (0.64) | MAPK8MAPK9MAPK10CALCRKEAP1 | |
| SCHEMBL30495769 | 0.88 | MAPK8 (0.69) | MAPK8MAPK9MAPK10CALCRKEAP1 | |
| SCHEMBL31182939 | 0.88 | MAPK8 (0.73) | MAPK8MAPK9MAPK10CALCRKEAP1 | |
| SCHEMBL30432747 | 0.88 | CALCR (0.70) | CALCRNPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL30712941 | 0.88 | MAPK8 (0.73) | MAPK8MAPK9MAPK10CALCRKEAP1 | |
| SCHEMBL30737437 | 0.87 | KDM1A (0.69) | MAPK8MAPK9MAPK10CALCRNPY2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 286 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4514879-B1 | POLYCARBONATE WITH PHENOLIC BUILDING BLOCKS AND LOW CHLORINE CONTENT | COVESTRO DEUTSCHLAND AG (DE) | 2026-03-04 | — | — | EP | claimed |
| EP-4514877-B1 | POLYCARBONATE COCONDENSATE WITH PHENOLIC BUILDING BLOCKS | COVESTRO DEUTSCHLAND AG (DE) | 2026-03-04 | — | — | EP | claimed |
| EP-4514878-B1 | AMORPHOUS COPOLYCARBONATE WITH PHENOLIC BUILDING BLOCKS | COVESTRO DEUTSCHLAND AG (DE) | 2026-03-04 | — | — | EP | claimed |
| EP-4085043-B1 | PROCESS FOR PREPARING AN ALPHA-SUBSTITUTED ACRYLATE | DOW GLOBAL TECHNOLOGIES LLC (US) | 2025-11-12 | — | — | EP | claimed |
| EP-4085042-B1 | PROCESS FOR PREPARING AN ALPHA-SUBSTITUTED ACRYLATE | DOW GLOBAL TECHNOLOGIES LLC (US) | 2025-09-03 | — | — | EP | claimed |
| EP-3310794-B1 | SYNTHESIS AND APPLICATION OF MICROBUBBLE-FORMING COMPOUNDS | CALIFORNIA INST OF TECHN (US) | 2025-08-06 | — | — | EP | claimed |
| EP-3687483-B1 | COMPOSITION FOR CARING FOR KERATIN FIBRES | OREAL (FR) | 2025-07-30 | — | — | EP | claimed |
| CN-112912094-B | Binding competitors for use in pharmaceutical assays for binding to megalin and methods of use thereof | 美国西门子医学诊断股份有限公司 | 2024-07-19 | — | — | CN | claimed |
| EP-3873509-B1 | BINDING COMPETITORS FOR USE IN MACROPHILIN-BINDING PHARMACEUTICAL ASSAYS AND METHODS OF USE THEREOF | SIEMENS HEALTHCARE DIAGNOSTICS INC (US) | 2024-06-12 | — | — | EP | claimed |
| US-11958863-B2 | Binding competitors for use in macrophilin-binding pharmaceutical assays and methods of use thereof | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2024-04-16 | — | — | US | claimed |
| EP-4185619-A1 | (METH)ACRYLATE FUNCTIONAL DISPERSANT | ARKEMA FRANCE (FR) | 2023-05-31 | — | — | EP | claimed |
| CN-116144004-A | Heterogeneous titanium catalyst for PBAT polymerization and preparation method and application thereof | 浙江理工大学 | 2023-05-23 | — | — | CN | claimed |
| CN-115867585-A | (meth) acrylate functional dispersants | 阿科玛法国公司 | 2023-03-28 | — | — | CN | claimed |
| CN-217656637-U | Home gateway with voice control function | 无锡市电子仪表工业有限公司 | 2022-10-25 | — | — | CN | claimed |
| US-20220229049-A1 | REAGENTS FOR SANDWICH IMMUNOASSAYS USING PARTICLE ENHANCED AGGLUTINATION DETECTION AND METHODS OF PRODUCTION AND USE THEREOF | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2022-07-21 | — | — | US | claimed |
| EP-3990923-A1 | REAGENTS FOR SANDWICH IMMUNOASSAYS USING PARTICLE ENHANCED AGGLUTINATION DETECTION AND METHODS OF PRODUCTION AND USE THEREOF | Siemens Healthcare Diagnostics, Inc. (US) | 2022-05-04 | — | — | EP | claimed |
| EP-3966201-A1 | THIOSEMICARBAZATES AND USES THEREOF | The Feinstein Institutes for Medical Research (US) | 2022-03-16 | — | — | EP | claimed |
| CN-114008457-A | Sandwich immunoassay reagents using particle-enhanced agglutination assays and methods of making and using same | 美国西门子医学诊断股份有限公司 | 2022-02-01 | — | — | CN | claimed |
| US-20220024946-A1 | BINDING COMPETITORS FOR USE IN MACROPHILIN-BINDING PHARMACEUTICAL ASSAYS AND METHODS OF USE THEREOF | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2022-01-27 | — | — | US | claimed |
| US-20260146138-A1 | METHODS OF RECYCLING POLYVINYL BUTYRAL | SOLUTIA INC. (US) | 2026-05-28 | — | — | US | disclosed |
| CN-122094978-A | Bioengineered immunomodulatory fusion protein compositions | — | 2026-05-26 | — | — | CN | disclosed |
| EP-4744053-A1 | SYSTEMS AND METHODS FOR PREDICTING BRAIN TAU OR AMYLOID LEVELS | Eisai R&D Management Co., Ltd. (JP) | 2026-05-20 | — | — | EP | disclosed |
| CN-111863131-B | Methods and processes for non-invasive assessment of chromosomal changes | 塞昆纳姆股份有限公司 | 2026-05-15 | — | — | CN | disclosed |
| EP-4735438-A2 | HETEROBIFUNCTIONAL COMPOUNDS FOR THE DEGRADATION OF KRAS | Merck Patent GmbH (DE) | 2026-05-06 | — | — | EP | disclosed |
| EP-4735452-A2 | HETEROBIFUNCTIONAL COMPOUNDS FOR THE DEGRADATION OF KRAS PROTEIN | Merck Patent GmbH (DE) | 2026-05-06 | — | — | EP | disclosed |
| US-20260108554-A1 | METHODS FOR REPROGRAMMING AND GENE EDITING CELLS | FACTOR BIOSCIENCE INC (US) | 2026-04-23 | — | — | US | disclosed |
| US-20260103652-A1 | MACROMOLECULAR CORROSION (McIn) INHIBITORS: STRUCTURES, METHODS OF MAKING AND USING THE SAME | POLNOX CORP (US) | 2026-04-16 | — | — | US | disclosed |
| US-12599181-B2 | Moisture lock fluid retention assemblies, garments including the same, and related methods | KNIX WEAR INC. (CA) | 2026-04-14 | — | — | US | disclosed |
| US-12600810-B2 | Process for preparing olefin-acrylate block copolymers | DOW GLOBAL TECHNOLOGIES LLC (US) | 2026-04-14 | — | — | US | disclosed |
| EP-4718326-A2 | NEURAL NETWORK QUANTIZATION PARAMETER DETERMINATION METHOD AND RELATED PRODUCTS | Shanghai Cambricon Information Technology Co., Ltd (CN) | 2026-04-01 | — | — | EP | disclosed |
| EP-4076360-B1 | COMPOSITION COMPRISING A SOLUBILIZED SOLID FATTY ALCOHOL AND A MONOALCOHOL | OREAL (FR) | 2026-03-25 | — | — | EP | disclosed |
| US-12584142-B2 | Transgenic plants having altered biomass composition | CERES, INC. (US) | 2026-03-24 | — | — | US | disclosed |
| CN-121609710-A | Condensed ring electron acceptor material containing imine bond and preparation and application thereof | 莆田学院 | 2026-03-06 | — | — | CN | disclosed |
| US-20260050068-A1 | GLARE-RESISTANT LIDAR | AEYE, INC. (US) | 2026-02-19 | — | — | US | disclosed |
| US-20260042995-A1 | ISOLATING AND LYSING CELLS | GEN-PROBE INCORPORATED (US) | 2026-02-12 | — | — | US | disclosed |
| US-20260037300-A1 | COMPUTE TILES | ADVANCED RISC MACH LTD (GB) | 2026-02-05 | — | — | US | disclosed |
| US-20260037270-A1 | HOST INSTRUCTIONS | ADVANCED RISC MACH LTD (GB) | 2026-02-05 | — | — | US | disclosed |
| US-20260037299-A1 | CLUSTER INSTRUCTIONS | ADVANCED RISC MACH LTD (GB) | 2026-02-05 | — | — | US | disclosed |
| US-20260037301-A1 | COMPUTE SYSTEM | ADVANCED RISC MACH LTD (GB) | 2026-02-05 | — | — | US | disclosed |
| US-12534562-B2 | Process for preparing olefin-acrylate block copolymers by ATRP | DOW GLOBAL TECHNOLOGIES LLC (US) | 2026-01-27 | — | — | US | disclosed |
| EP-4676225-A1 | FUNGICIDAL COMBINATIONS, MIXTURES AND COMPOSITIONS AND USES THEREOF | Adama Makhteshim Ltd. (IL) | 2026-01-14 | — | — | EP | disclosed |
| EP-4675502-A2 | METHOD FOR DETERMINING QUANTIZATION PARAMETER OF NEURAL NETWORK, AND RELATED PRODUCT | Shanghai Cambricon Information Technology Co., Ltd (CN) | 2026-01-07 | — | — | EP | disclosed |
| US-12508707-B2 | Control devices for end effectors with multi-axis roller wheels, systems including the same, and related methods | THE BOEING COMPANY (US) | 2025-12-30 | — | — | US | disclosed |
| US-20250381317-A1 | COLLAGEN COMPOSITIONS AND METHODS OF USE THEREOF | MODERN MEADOW INC (US) | 2025-12-18 | — | — | US | disclosed |
| EP-4661835-A1 | COMPOSITION COMPRISING AT LEAST ONE AMINO ACID, AT LEAST ONE ASSOCIATIVE POLYURETHANE, AT LEAST ONE PARTICULAR POLYSACCHARIDE AND AT LEAST ONE AMINO SILICONE | L'OREAL (FR) | 2025-12-17 | — | — | EP | disclosed |
| US-12492352-B2 | Macromolecular corrosion (MCIN) inhibitors: structures, methods of making and using the same | POLNOX CORPORATION (US) | 2025-12-09 | — | — | US | disclosed |
| US-20250366468-A1 | MIXTURES AND COMPOSITIONS COMPRISING 5-FLUORO-4-IMINO-3-METHYL-1-TOSYL-3,4-DIHYDROPYRIMIDIN-2-ONE, AND METHODS OF USE THEREOF | ADAMA MAKHTESHIM LTD. (IL) | 2025-12-04 | — | — | US | disclosed |
| US-20250338845-A1 | FUNGICIDAL COMBINATIONS, MIXTURES AND COMPOSITIONS AND USES THEREOF | ADAMA MAKHTESHIM LTD. (IL) | 2025-11-06 | — | — | US | disclosed |
| EP-3870305-B1 | HAIR SHAPING PROCESS USING A COMPOSITION COMPRISING AT LEAST ONE SILICONE ACRYLIC COPOLYMER | OREAL (FR) | 2025-11-05 | — | — | EP | disclosed |
| US-12447207-B2 | Human cytomegalovirus gB polypeptide | PFIZER INC. (US) | 2025-10-21 | — | — | US | disclosed |
| EP-4627739-A1 | METHODS FOR TRANSMITTING DATA VIA FREE SPACE SPATIOTEMPORAL PATTERNS | Microsoft Technology Licensing, LLC (US) | 2025-10-08 | — | — | EP | disclosed |
| EP-4627740-A1 | METHODS FOR TRANSMITTING DATA VIA FREE SPACE SPATIOTEMPORAL PATTERNS | Microsoft Technology Licensing, LLC (US) | 2025-10-08 | — | — | EP | disclosed |
| US-12435071-B2 | Bryostatin compounds and methods of preparing the same | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2025-10-07 | — | — | US | disclosed |
| US-12414559-B2 | Mixtures and compositions comprising 5-fluoro-4-imino-3-methyl-1-tosyl-3,4-dihydropyrimidin-2-one, and methods of use thereof | ADAMA MAKHTESHIM LTD. (IL) | 2025-09-16 | — | — | US | disclosed |
| EP-4608441-A1 | IMMUNOGENIC COMPOSITIONS AGAINST INFLUENZA AND RSV | Pfizer Inc. (US) | 2025-09-03 | — | — | EP | disclosed |
| EP-4609713-A2 | FUNGICIDAL COMBINATIONS, MIXTURES AND COMPOSITIONS AND USES THEREOF | ADAMA MAKHTESHIM LTD. (IL) | 2025-09-03 | — | — | EP | disclosed |
| EP-4603231-A1 | CONTROL DEVICES FOR END EFFECTORS WITH MULTI-AXIS ROLLER WHEELS, SYSTEMS INCLUDING THE SAME, AND RELATED METHODS | The Boeing Company (US) | 2025-08-20 | — | — | EP | disclosed |
| US-12391954-B2 | Transgenic plants having altered biomass composition | CERES, INC. (US) | 2025-08-19 | — | — | US | disclosed |
| US-20250254346-A1 | PARAMETER DERIVATION IN CROSS COMPONENT MODE | BEIJING BYTEDANCE NETWORK TECHNOLOGY CO., LTD. (CN) | 2025-08-07 | — | — | US | disclosed |
| US-20250234939-A1 | MOISTURE LOCK FLUID RETENTION ASSEMBLIES, GARMENTS INCLUDING THE SAME, AND RELATED METHODS | KNIX WEAR INC. (CA) | 2025-07-24 | — | — | US | disclosed |
| EP-4588463-A1 | MOISTURE LOCK FLUID RETENTION ASSEMBLIES, GARMENTS INCLUDING THE SAME, AND RELATED METHODS | Knix Wear Inc. (CA) | 2025-07-23 | — | — | EP | disclosed |
| WO-2025126050-A1 | CHIMERIC ADJUVANT | DANGERFIELD EMMA (NZ) | 2025-06-19 | — | — | WO | disclosed |
| CN-120153018-A | Process for recovering polyvinyl butyrals | 首诺公司 | 2025-06-13 | — | — | CN | disclosed |
| EP-4566450-A2 | FUNGICIDAL COMBINATIONS, MIXTURES AND COMPOSITIONS AND USES THEREOF | ADAMA MAKHTESHIM LTD. (IL) | 2025-06-11 | — | — | EP | disclosed |
| US-20250176549-A1 | FUNGICIDAL COMBINATIONS, MIXTURES AND COMPOSITIONS AND USES THEREOF | ADAMA MAKHTESHIM LTD. (IL) | 2025-06-05 | — | — | US | disclosed |
| US-12311406-B2 | Methods for producing optical effect layers comprising magnetic or magnetizable pigment particles and exhibiting one or more indicia | SICPA HOLDING SA (CH) | 2025-05-27 | — | — | US | disclosed |
| US-12316377-B2 | Methods for transmitting data via free space spatiotemporal patterns | MICROSOFT TECHNOLOGY LICENSING, LLC (US) | 2025-05-27 | — | — | US | disclosed |
| EP-3897146-B1 | ANTIMICROBIAL MIXTURE CONTAINING 4-(3-ETHOXY-4-HYDROXYPHENYL) BUTAN-2-ONE, AND 4-HYDROXYACETOPHENONE, AND COMPOSITION CONTAINING SAME | OREAL (FR) | 2025-05-21 | — | — | EP | disclosed |
| EP-4554715-A1 | METHOD FOR PREPARING POROUS ADSORBENT PARTICLES, A POROUS ADSORBENT PARTICLE AND SAMPLING DEVICE, AND USE THEREOF | Imperial College Innovations Limited (GB) | 2025-05-21 | — | — | EP | disclosed |
| US-12301845-B2 | Parameter derivation in cross component mode | BEIJING BYTEDANCE NETWORK TECHNOLOGY CO., LTD. (CN) | 2025-05-13 | — | — | US | disclosed |
| US-20250143981-A1 | AEROSOL DEVICE CONTAINING A COMPOSITION COMPRISING A BRANCHED ALKANE, A FATTY SUBSTANCE AND A PROPELLANT | OREAL (FR) | 2025-05-08 | — | — | US | disclosed |
| WO-2025090988-A1 | METHODS FOR PRODUCING SMALL HALOGENATED COMPOUNDS FROM PEROXY ACIDS | BIGELOW LABORATORY FOR OCEAN SCIENCES (US) | 2025-05-01 | — | — | WO | disclosed |
| WO-2025074281-A1 | OLEFINIC QUATERNARY AMMONIUM COMPOUNDS | AUCKLAND UNISERVICES LIMITED (NZ) | 2025-04-10 | — | — | WO | disclosed |
| EP-4531570-A1 | FUNGICIDAL COMBINATIONS, MIXTURES AND COMPOSITIONS AND USES THEREOF | ADAMA MAKHTESHIM LTD. (IL) | 2025-04-09 | — | — | EP | disclosed |
| EP-4531795-A2 | COLLAGEN COMPOSITIONS AND METHODS OF USE THEREOF | HTL Biotechnology Innovation, Inc. (US) | 2025-04-09 | — | — | EP | disclosed |
| WO-2025068507-A1 | RHEOLOGY CONTROL AGENT | BYK-CHEMIE GMBH (DE) | 2025-04-03 | — | — | WO | disclosed |
| WO-2025072678-A1 | PROCESS FOR PREPARING AN OLEFIN-ACRYLATE BLOCK COPOLYMER | DOW GLOBAL TECHNOLOGIES LLC (US) | 2025-04-03 | — | — | WO | disclosed |
| WO-2025072528-A1 | NICOTINE COMPLEXES AND METHODS OF USE IN THE ADJUSTMENT OF NICOTINE HARSHNESS AND RELEASE KINETICS | SCIENTIFIC HORIZONS CONSULTING LLC (US) | 2025-04-03 | — | — | WO | disclosed |
| WO-2025072539-A1 | AMINO ACID COMPOUNDS WITH NITROGEN LINKERS AND USES THEREOF | PLIANT THERAPEUTICS, INC. (US) | 2025-04-03 | — | — | WO | disclosed |
| CN-119730954-A | Preparation method of porous adsorbent particles, sampling device and application of porous adsorbent particles | 英皇学院创新有限公司 | 2025-03-28 | — | — | CN | disclosed |
| CN-115803353-B | Process for preparing olefin-acrylate block copolymers by RAFT polymerization | 陶氏环球技术有限责任公司 | 2025-03-14 | — | — | CN | disclosed |
| WO-2025051913-A1 | COSMETIC COMPOSITION COMPRISING A SOLID FATTY ALCOHOL, A CATIONIC SURFACTANT, AN AMPHOTERIC SURFACTANT, A PARTICULAR NONIONIC POLYSACCHARIDE AND A CATIONIC POLYMER | L'OREAL (FR) | 2025-03-13 | — | — | WO | disclosed |
| CN-119603814-A | Induction heating cooker | 松下知识产权经营株式会社 | 2025-03-11 | — | — | CN | disclosed |
| WO-2025046493-A1 | BIOENGINEERED IMMUNOMODULATORY FUSION PROTEIN COMPOSITIONS | JANSSEN BIOTECH, INC. (US) | 2025-03-06 | — | — | WO | disclosed |
| CN-119562802-A | Collagen compositions and methods of use thereof | HTL生物创新股份有限公司 | 2025-03-04 | — | — | CN | disclosed |
| US-20250053485-A1 | NEURAL NETWORK QUANTIZATION PARAMETER DETERMINATION METHOD AND RELATED PRODUCTS | SHANGHAI CAMBRICON INFORMATION TECHNOLOGY CO., LTD (CN) | 2025-02-13 | — | — | US | disclosed |
| WO-2025019463-A1 | SYSTEMS AND METHODS FOR PREDICTING BRAIN TAU OR AMYLOID LEVELS | EISAI R & D MANAGEMENT CO., LTD. (JP) | 2025-01-23 | — | — | WO | disclosed |
| US-12198809-B2 | Machine learning algorithms for detecting medical conditions, related systems, and related methods | EVANS NEIL REZA SHADBEH (US) | 2025-01-14 | — | — | US | disclosed |
| US-20250011392-A1 | COLLAGEN COMPOSITIONS AND METHODS OF USE THEREOF | HTL BIOTECHNOLOGY INNOVATION INC. | 2025-01-09 | — | — | US | disclosed |
| EP-4486126-A1 | FUNGICIDAL COMBINATIONS, MIXTURES AND COMPOSITIONS AND USES THEREOF | ADAMA MAKHTESHIM LTD. (IL) | 2025-01-08 | — | — | EP | disclosed |
| WO-2025006783-A2 | HETEROBIFUNCTIONAL COMPOUNDS FOR THE DEGRADATION OF KRAS | MERCK PATENT GMBH (DE) | 2025-01-02 | — | — | WO | disclosed |
| WO-2025006753-A2 | HETEROBIFUNCTIONAL COMPOUNDS FOR THE DEGRADATION OF KRAS PROTEIN | MERCK PATENT GMBH (DE) | 2025-01-02 | — | — | WO | disclosed |
| US-12171909-B2 | Implants having a drug load of an oxysterol and methods of use | WARSAW ORTHOPEDIC, INC. (US) | 2024-12-24 | — | — | US | disclosed |
| US-12171665-B2 | Compression resistant implants including an oxysterol and methods of use | WARSAW ORTHOPEDIC, INC. (US) | 2024-12-24 | — | — | US | disclosed |
| EP-4469014-A1 | AEROSOL DEVICE CONTAINING A COMPOSITION COMPRISING A BRANCHED ALKANE, A FATTY SUBSTANCE AND A PROPELLANT | L'OREAL (FR) | 2024-12-04 | — | — | EP | disclosed |
| CN-110048281-B | Electric connector | 连展科技（深圳）有限公司 | 2024-11-29 | — | — | CN | disclosed |
| US-20240390258-A1 | FOAMING COMPOSITION | L'OREAL (FR) | 2024-11-28 | — | — | US | disclosed |
| US-12151016-B2 | Hair shaping process using a composition comprising at least one silicone acrylic copolymer | L'OREAL (FR) | 2024-11-26 | — | — | US | disclosed |
| CN-118973399-A | Fungicidal combinations, mixtures and combinations and use thereof | 安道麦马克西姆有限公司 | 2024-11-15 | — | — | CN | disclosed |
| WO-2024223762-A1 | A METHOD FOR SYNTHESIZING HALIDE SALTS, A HALIDE SALT BASED PEROVSKITE INK AND POWDER AND A HALIDE SALT BASED PEROVSKITE | FUNDACJA SAULE RESEARCH INSTITUTE (PL) | 2024-10-31 | — | — | WO | disclosed |
| US-20240360284-A1 | CORE-SHELL MICROCAPSULES, MANUFACTURING PROCESSES AND USES | DROPLET GENOMICS, UAB (LT) | 2024-10-31 | — | — | US | disclosed |
| EP-4455153-A1 | A METHOD FOR SYNTHESIZING HALIDE SALTS, A HALIDE SALT BASED PEROVSKITE INK AND POWDER AND A HALIDE SALT BASED PEROVSKITE | Fundacja Saule Research Institute (PL) | 2024-10-30 | — | — | EP | disclosed |
| US-20240337487-A1 | SENSOR READING CORRECTION | AQUATIC INFORMATICS ULC (CA) | 2024-10-10 | — | — | US | disclosed |
| US-20240337506-A1 | SENSOR READING CORRECTION | AQUATIC INFORMATICS ULC (CA) | 2024-10-10 | — | — | US | disclosed |
| US-20240337486-A1 | SENSOR READING CORRECTION | AQUATICS INFORMATICS ULC (CA) | 2024-10-10 | — | — | US | disclosed |
| EP-4440736-A1 | CORE-SHELL MICROCAPSULES, MANUFACTURING PROCESSES AND USES | Droplet Genomics, Uab (LT) | 2024-10-09 | — | — | EP | disclosed |
| WO-2024199925-A1 | FLUID CARE AND/OR MAKE-UP COMPOSITION WITH AN ESTER OIL, A POROUS SPHERICAL SILICA, A NON-POROUS COMPOSITE SILICA, BORON NITRIDE, ULTRAMARINE BLUE AND TITANIUM DIOXIDE | L'OREAL (FR) | 2024-10-03 | — | — | WO | disclosed |
| US-12101992-B2 | Organic semiconducting compounds | Raynergy Tek Incorporation (TW) | 2024-09-24 | — | — | US | disclosed |
| EP-4429704-A1 | IONIC LIQUID COMPOSITIONS | I2O Therapeutics, Inc. (US) | 2024-09-18 | — | — | EP | disclosed |
| US-12093148-B2 | Neural network quantization parameter determination method and related products | SHANGHAI CAMBRICON INFORMATION TECHNOLOGY CO., LTD (CN) | 2024-09-17 | — | — | US | disclosed |
| WO-2024184859-A1 | FUNGICIDAL COMBINATIONS, MIXTURES AND COMPOSITIONS AND USES THEREOF | CONESE SALVATORE (DE) | 2024-09-12 | — | — | WO | disclosed |
| US-12077486-B2 | Quaternary fatty amidoamine detergents | NOURYON CHEMICALS INTERNATIONAL B.V. (NL) | 2024-09-03 | — | — | US | disclosed |
| CN-118541170-A | Ionic liquid composition | I2O治疗公司 | 2024-08-23 | — | — | CN | disclosed |
| WO-2024165675-A1 | COMPOSITION COMPRISING AT LEAST ONE AMINO ACID, AT LEAST ONE ASSOCIATIVE POLYURETHANE, AT LEAST ONE PARTICULAR POLYSACCHARIDE AND AT LEAST ONE AMINO SILICONE | L'OREAL (FR) | 2024-08-15 | — | — | WO | disclosed |
| US-20240270661-A1 | COATED GRANULAR SUBSTANCE, METHOD FOR COATING A GRANULAR SUBSTANCE AND USE OF A BINDER FOR COATING A GRANULAR SUBSTANCE | ASK CHEMICALS GMBH (DE) | 2024-08-15 | — | — | US | disclosed |
| US-20240261291-A1 | Ophthalmic Compositions and/or Methods for Presbyopia, Mydriasis and/or Ocular Discomfort Management | BRIEN HOLDEN VISION INSTITUTE LTD (AU) | 2024-08-08 | — | — | US | disclosed |
| WO-2024160232-A1 | PLASMID PACKAGING SYSTEM AND USE THEREOF | 纽福斯(苏州)生物科技有限公司 | 2024-08-08 | — | — | WO | disclosed |
| EP-4406614-A2 | BINDING COMPETITORS FOR USE IN MACROPHILIN-BINDING PHARMACEUTICALS ASSAYS AND METHODS OF USE THEREOF | Siemens Healthcare Diagnostics Inc. (US) | 2024-07-31 | — | — | EP | disclosed |
| CN-112912094-B | Binding competitors for use in pharmaceutical assays for binding to megalin and methods of use thereof | 美国西门子医学诊断股份有限公司 | 2024-07-19 | — | — | CN | disclosed |
| CN-113365697-B | Anti-TLR 9 agents and compositions, methods of making and using the same | 百进生物科技公司 | 2024-07-19 | — | — | CN | disclosed |
| US-20240238839-A1 | METHODS FOR PRODUCING OPTICAL EFFECT LAYERS COMPRISING MAGNETIC OR MAGNETIZABLE PIGMENT PARTICLES AND EXHIBITING ONE OR MORE INDICIA | SICPA HOLDING SA (CH) | 2024-07-18 | — | — | US | disclosed |
| US-20240237649-A1 | CRYSTALLINE FORMS OF 5-FLUORO-4-IMINO-3-METHYL-1-TOSYL-3,4-DIHYDROPYRIMIDIN-2-ONE, AND MIXTURES, COMPOSITIONS AND METHODS OF USE THEREOF | ADAMA MAKHTESHIM LTD. (IL) | 2024-07-18 | — | — | US | disclosed |
| CN-118354843-A | Core-shell microcapsule, preparation process and application | 液滴基因组学私人有限公司 | 2024-07-16 | — | — | CN | disclosed |
| US-20240218083-A1 | MOLECULES WITH ENGINEERED ANTIBODY CONSTANT REGION VARIANTS | JANSSEN BIOTECH, INC. | 2024-07-04 | — | — | US | disclosed |
| US-20240208996-A1 | BINDING COMPETITORS FOR USE IN MACROPHILIN-BINDING PHARMACEUTICAL ASSAYS AND METHODS OF USE THEREOF | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2024-06-27 | — | — | US | disclosed |
| WO-2024134667-A1 | A DEVICE COMPRISING OXIDATIVE COMPOSITION FOR DYEING OF KERATIN FIBRES | L'OREAL (FR) | 2024-06-27 | — | — | WO | disclosed |
| CN-118251492-A | PMP 22-targeting compounds for the treatment of summer-Mary-Tuber disease | 诺华股份有限公司 | 2024-06-25 | — | — | CN | disclosed |
| EP-4385647-A1 | METHODS OF ADDITIVELY MANUFACTURING A MANUFACTURED COMPONENT, ADDITIVE MANUFACTURING SYSTEMS THAT PERFORM THE METHODS, AND STORAGE MEDIA THAT DIRECTS ADDITIVE MANUFACTURING SYSTEMS TO PERFORM THE METHODS | The Boeing Company (US) | 2024-06-19 | — | — | EP | disclosed |
| EP-4385646-A1 | METHODS OF ADDITIVELY MANUFACTURING A MANUFACTURED COMPONENT, ADDITIVE MANUFACTURING SYSTEMS THAT PERFORM THE METHODS, AND STORAGE MEDIA THAT DIRECTS ADDITIVE MANUFACTURING SYSTEMS TO PERFORM THE METHODS | The Boeing Company (US) | 2024-06-19 | — | — | EP | disclosed |
| EP-4385645-A1 | METHODS OF ADDITIVELY MANUFACTURING A MANUFACTURED COMPONENT, ADDITIVE MANUFACTURING SYSTEMS THAT PERFORM THE METHODS, AND STORAGE MEDIA THAT DIRECTS ADDITIVE MANUFACTURING SYSTEMS TO PERFORM THE METHODS | The Boeing Company (US) | 2024-06-19 | — | — | EP | disclosed |
| CN-118180414-A | Method of additive manufacturing a manufactured part, additive manufacturing system, and storage medium | 波音公司 | 2024-06-14 | — | — | CN | disclosed |
| US-20240190083-A1 | METHODS OF ADDITIVELY MANUFACTURING A MANUFACTURED COMPONENT, ADDITIVE MANUFACTURING SYSTEMS THAT PERFORM THE METHODS, AND STORAGE MEDIA THAT DIRECTS ADDITIVE MANUFACTURING SYSTEMS TO PERFORM THE METHODS | THE BOEING COMPANY | 2024-06-13 | — | — | US | disclosed |
| US-20240190857-A1 | METHODS FOR MANUFACTURE OF SMALL MOLECULE ACTIVATORS OF TIE-2 | EyePoint, Inc. | 2024-06-13 | — | — | US | disclosed |
| US-20240190081-A1 | METHODS OF ADDITIVELY MANUFACTURING A MANUFACTURED COMPONENT, ADDITIVE MANUFACTURING SYSTEMS THAT PERFORM THE METHODS, AND STORAGE MEDIA THAT DIRECTS ADDITIVE MANUFACTURING SYSTEMS TO PERFORM THE METHODS | THE BOEING COMPANY | 2024-06-13 | — | — | US | disclosed |
| EP-3873509-B1 | BINDING COMPETITORS FOR USE IN MACROPHILIN-BINDING PHARMACEUTICAL ASSAYS AND METHODS OF USE THEREOF | SIEMENS HEALTHCARE DIAGNOSTICS INC (US) | 2024-06-12 | — | — | EP | disclosed |
| US-20240181640-A1 | CONTROL DEVICES FOR END EFFECTORS WITH MULTI-AXIS ROLLER WHEELS, SYSTEMS INCLUDING THE SAME, AND RELATED METHODS | THE BOEING COMPANY | 2024-06-06 | — | — | US | disclosed |
| WO-2024118174-A1 | METHODS FOR TRANSMITTING DATA VIA FREE SPACE SPATIOTEMPORAL PATTERNS | MICROSOFT TECHNOLOGY LICENSING, LLC (US) | 2024-06-06 | — | — | WO | disclosed |
| WO-2024118173-A1 | METHODS FOR TRANSMITTING DATA VIA FREE SPACE SPATIOTEMPORAL PATTERNS | MICROSOFT TECHNOLOGY LICENSING, LLC (US) | 2024-06-06 | — | — | WO | disclosed |
| US-20240176976-A1 | METHODS FOR TRANSMITTING DATA VIA FREE SPACE SPATIOTEMPORAL PATTERNS | MICROSOFT TECHNOLOGY LICENSING, LLC | 2024-05-30 | — | — | US | disclosed |
| US-20240178918-A1 | METHODS FOR TRANSMITTING DATA VIA FREE SPACE SPATIOTEMPORAL PATTERNS | MICROSOFT TECHNOLOGY LICENSING, LLC | 2024-05-30 | — | — | US | disclosed |
| US-20240172750-A1 | 5-Fluoro-4-Imino-3-Methyl-1-Tosyl-3,4-Dihydropyrimidin-2(1H)-One for Controlling Plant Diseases | ADAMA MAKHTESHIM LTD. (IL) | 2024-05-30 | — | — | US | disclosed |
| US-20240179402-A1 | METHODS FOR TRANSMITTING DATA VIA FREE SPACE SPATIOTEMPORAL PATTERNS IN A DATACENTER | MICROSOFT TECHNOLOGY LICENSING, LLC | 2024-05-30 | — | — | US | disclosed |
| WO-2024089634-A1 | IMMUNOGENIC COMPOSITIONS AGAINST INFLUENZA AND RSV | PFIZER INC. (US) | 2024-05-02 | — | — | WO | disclosed |
| EP-4359367-A1 | COATED GRANULAR SUBSTANCE, METHOD FOR COATING A GRANULAR SUBSTANCE AND USE OF A BINDER FOR COATING A GRANULAR SUBSTANCE | ASK Chemicals GmbH (DE) | 2024-05-01 | — | — | EP | disclosed |
| CN-113711590-B | Reducing delay in cross-component mode | 北京字节跳动网络技术有限公司 | 2024-04-19 | — | — | CN | disclosed |
| CN-117897058-A | Collagen compositions and methods of use thereof | 现代牧场股份有限公司 | 2024-04-16 | — | — | CN | disclosed |
| US-11958947-B2 | Core-shell microcapsules, manufacturing processes and uses | DROPLET GENOMICS, UAB (LT) | 2024-04-16 | — | — | US | disclosed |
| US-11958863-B2 | Binding competitors for use in macrophilin-binding pharmaceutical assays and methods of use thereof | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2024-04-16 | — | — | US | disclosed |
| US-20240116908-A1 | BRYOSTATIN COMPOUNDS AND METHODS OF PREPARING THE SAME | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 2024-04-11 | — | — | US | disclosed |
| EP-3091958-B1 | COSMETIC COMPOSITION COMPRISING CATIONIC SURFACTANT(S), ANTIDANDRUFF AGENT(S), LIQUID NON-SILICEOUS FATTY SUBSTANCE(S), AND NON-POLYMERIC THICKENING AGENT(S) | OREAL (FR) | 2024-04-03 | — | — | EP | disclosed |
| US-20240099955-A1 | SKINCARE COMPOSITIONS AND METHODS OF USE THEREOF | HTL BIOTECHNOLOGY INNOVATION INC. | 2024-03-28 | — | — | US | disclosed |
| US-20240100153-A1 | HUMAN CYTOMEGALOVIRUS GB POLYPEPTIDE | PFIZER (US) | 2024-03-28 | — | — | US | disclosed |
| WO-2024051766-A1 | MOLECULAR GLUE COMPOUND BASED ON CEREBLON PROTEIN DESIGN AND USE THEREOF | 标新生物医药科技(上海)有限公司 | 2024-03-14 | — | — | WO | disclosed |
| EP-4329521-A2 | COLLAGEN COMPOSITIONS AND METHODS OF USE THEREOF | Modern Meadow, Inc. (US) | 2024-03-06 | — | — | EP | disclosed |
| US-20240065950-A1 | AEROSOL DEVICE CONTAINING A COMPOSITION COMPRISING A SOLID FATTY ALCOHOL, A MONOALCOHOL AND A COMPRESSED GAS | L'OREAL (FR) | 2024-02-29 | — | — | US | disclosed |
| EP-4326323-A1 | MOLECULES WITH ENGINEERED ANTIBODY CONSTANT REGION VARIANTS | Janssen Biotech, Inc. (US) | 2024-02-28 | — | — | EP | disclosed |
| WO-2024035861-A1 | GLARE-RESISTANT LIDAR | AEYE, INC. (US) | 2024-02-15 | — | — | WO | disclosed |
| US-20240050336-A1 | AEROSOL DEVICE CONTAINING A COMPOSITION COMPRISING A SOLID FATTY ALCOHOL AND A LIQUEFIED GAS | L'OREAL (FR) | 2024-02-15 | — | — | US | disclosed |
| US-11896694-B2 | Compositions for removing nail polish | L'OREAL (FR) | 2024-02-13 | — | — | US | disclosed |
| CN-117545505-A | Molecules with engineered antibody constant region variants | 詹森生物科技公司 | 2024-02-09 | — | — | CN | disclosed |
| EP-4313430-A1 | METHODS FOR PRODUCING OPTICAL EFFECT LAYERS COMPRISING MAGNETIC OR MAGNETIZABLE PIGMENT PARTICLES AND EXHIBITING ONE OR MORE INDICIA | Sicpa Holding SA (CH) | 2024-02-07 | — | — | EP | disclosed |
| EP-3797636-B1 | METHOD FOR SHAPING HAIR USING SURFACTANTS | OREAL (FR) | 2024-02-07 | — | — | EP | disclosed |
| CN-117521550-A | River network hydrodynamic force simulation method based on physical knowledge and data double driving | 河海大学 | 2024-02-06 | — | — | CN | disclosed |
| CN-117528068-A | Selective use in cross-component modes in video coding | 北京字节跳动网络技术有限公司 | 2024-02-06 | — | — | CN | disclosed |
| CN-117460448-A | Multiparameter materials, methods, and systems for bioreactor saccharified material fabrication | 詹森生物科技公司 | 2024-01-26 | — | — | CN | disclosed |
| EP-4308093-A1 | TOPICAL PHARMACEUTICAL COMPOSITION COMPRISING AMITRIPTYLINE AND AN ALKALINE AQUEOUS PHASE | Algotherapeutix (FR) | 2024-01-24 | — | — | EP | disclosed |
| WO-2024013083-A1 | METHOD FOR PREPARING POROUS ADSORBENT PARTICLES, A POROUS ADSORBENT PARTICLE AND SAMPLING DEVICE, AND USE THEREOF | IMPERIAL COLLEGE INNOVATIONS LIMITED (GB) | 2024-01-18 | — | — | WO | disclosed |
| US-20240023153-A1 | REDUCING POWER CONSUMPTION FOR DEVICE-TO-DEVICE COMMUNICATION | Sony Group Corporation (JP) | 2024-01-18 | — | — | US | disclosed |
| US-11857622-B2 | Human cytomegalovirus GB polypeptide | PFIZER INC. (US) | 2024-01-02 | — | — | US | disclosed |
| US-20230399654-A1 | TRANSGENIC PLANTS HAVING ALTERED BIOMASS COMPOSITION | CERES INC (US) | 2023-12-14 | — | — | US | disclosed |
| EP-4288084-A1 | SKINCARE COMPOSITIONS AND METHODS OF USE THEREOF | Modern Meadow, Inc. (US) | 2023-12-13 | — | — | EP | disclosed |
| WO-2023235775-A2 | COLLAGEN COMPOSITIONS AND METHODS OF USE THEREOF | MODERN MEADOW, INC. (US) | 2023-12-07 | — | — | WO | disclosed |
| EP-4284173-A1 | 5-FLUORO-4-IMINO-3-METHYL-1-TOSYL-3,4-DIHYDROPYRIMIDIN-2(1 H)-ONE FOR CONTROLLING PLANT DISEASES | ADAMA MAKHTESHIM LTD. (IL) | 2023-12-06 | — | — | EP | disclosed |
| WO-2023228148-A1 | FUNGICIDAL COMBINATIONS, MIXTURES AND COMPOSITIONS AND USES THEREOF | ADAMA MAKHTESHIM LTD. (IL) | 2023-11-30 | — | — | WO | disclosed |
| CN-117119889-A | 5-fluoro-4-imino-3-methyl-1-tosyl-3, 4-dihydropyrimidin-2 (1H) -one for controlling plant diseases | 安道麦马克西姆有限公司 | 2023-11-24 | — | — | CN | disclosed |
| CN-117098610-A | Method for producing an optical effect layer comprising magnetic or magnetizable pigment particles and exhibiting more than one marking | 锡克拜控股有限公司 | 2023-11-21 | — | — | CN | disclosed |
| WO-2023215724-A1 | METHODS FOR REPROGRAMMING AND GENE EDITING CELLS | FACTOR BIOSCIENCE INC. (US) | 2023-11-09 | — | — | WO | disclosed |
| US-11807397-B2 | Systems and methods for assembling containerized aircraft | THE BOEING COMPANY (US) | 2023-11-07 | — | — | US | disclosed |
| CN-113692742-B | Selective use in cross-component modes in video coding | 北京字节跳动网络技术有限公司 | 2023-10-27 | — | — | CN | disclosed |
| CN-113692739-B | Constraints on availability of cross-component patterns | 北京字节跳动网络技术有限公司 | 2023-10-27 | — | — | CN | disclosed |
| US-20230340210-A1 | CORE-SHELL MICROCAPSULES, MANUFACTURING PROCESSES AND USES | DROPLET GENOMICS, UAB (LT) | 2023-10-26 | — | — | US | disclosed |
| EP-4262690-A1 | AEROSOL DEVICE CONTAINING A COMPOSITION COMPRISING A SOLID FATTY ALCOHOL AND A LIQUEFIED GAS | L'OREAL (FR) | 2023-10-25 | — | — | EP | disclosed |
| EP-4262794-A1 | METHODS FOR MANUFACTURE OF SMALL MOLECULE ACTIVATORS OF TIE-2 | EyePoint Pharmaceuticals, Inc. (US) | 2023-10-25 | — | — | EP | disclosed |
| EP-4262682-A1 | AEROSOL DEVICE CONTAINING A COMPOSITION COMPRISING A SOLID FATTY ALCOHOL, A MONOALCOHOL AND A COMPRESSED GAS | L'OREAL (FR) | 2023-10-25 | — | — | EP | disclosed |
| CN-116940355-A | Method for manufacturing small molecule activators of TIE-2 | 视点制药公司 | 2023-10-24 | — | — | CN | disclosed |
| US-20230321212-A1 | GROUP B STREPTOCOCCUS POLYSACCHARIDE-PROTEIN CONJUGATES, METHODS FOR PRODUCING CONJUGATES, IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATES, AND USES THEREOF | PFIZER (US) | 2023-10-12 | — | — | US | disclosed |
| EP-3389613-B1 | COSMETIC COMPOSITION COMPRISING AN ANIONIC SURFACTANT, AT LEAST 3.5% BY WEIGHT OF A FATTY ACID AND AN ANTIDANDRUFF AGENT | OREAL (FR) | 2023-10-11 | — | — | EP | disclosed |
| CN-116847871-A | Skin care compositions and methods of use | 现代牧场股份有限公司 | 2023-10-03 | — | — | CN | disclosed |
| US-20230295353-A1 | (METH)ACRYLATE FUNCTIONAL DISPERSANT | ARKEMA FRANCE (FR) | 2023-09-21 | — | — | US | disclosed |
| US-20230292746-A1 | MIXTURES AND COMPOSITIONS COMPRISING 5-FLUORO-4-IMINO-3- METHYL-1-TOSYL-3,4-DIHYDROPYRIMIDIN-2-ONE, AND METHODS OF USE THEREOF | ADAMA MAKHTESHIM LTD. (IL) | 2023-09-21 | — | — | US | disclosed |
| US-20230277607-A1 | Natural non-pathogenic microorganisms capable of associating glycolipids or lipopeptides and use thereof | ACARYON GMBH (DE) | 2023-09-07 | — | — | US | disclosed |
| WO-2023166485-A1 | FUNGICIDAL COMBINATIONS, MIXTURES AND COMPOSITIONS AND USES THEREOF | ADAMA MAKHTESHIM LTD. (IL) | 2023-09-07 | — | — | WO | disclosed |
| US-11746105-B2 | Bryostatin compounds and methods of preparing the same | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2023-09-05 | — | — | US | disclosed |
| WO-2023151635-A1 | COMPOUND BASED ON QUINAZOLINE-SUBSTITUTED GLUTARIMIDE SKELETON AND USE THEREOF | 标新生物医药科技(上海)有限公司 | 2023-08-17 | — | — | WO | disclosed |
| WO-2023144156-A1 | AEROSOL DEVICE CONTAINING A COMPOSITION COMPRISING A BRANCHED ALKANE, A FATTY SUBSTANCE AND A PROPELLANT | L'OREAL (FR) | 2023-08-03 | — | — | WO | disclosed |
| EP-4203995-A1 | GROUP B STREPTOCOCCUS POLYSACCHARIDE-PROTEIN CONJUGATES, METHODS FOR PRODUCING CONJUGATES, IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATES, AND USES THEREOF | Pfizer Inc. (US) | 2023-07-05 | — | — | EP | disclosed |
| CN-116348131-A | Human cytomegalovirus gB polypeptides | 辉瑞公司 | 2023-06-27 | — | — | CN | disclosed |
| US-20230200202-A1 | ORGANIC SEMICONDUCTING COMPOUNDS | Raynergy Tek Incorporation (TW) | 2023-06-22 | — | — | US | disclosed |
| CN-116249449-A | Compositions and methods for preparing N-phenylpyrazole-1-carboxamides | FMC公司 | 2023-06-09 | — | — | CN | disclosed |
| WO-2023099610-A1 | CORE-SHELL MICROCAPSULES, MANUFACTURING PROCESSES AND USES | DROPLET GENOMICS, UAB (LT) | 2023-06-08 | — | — | WO | disclosed |
| US-11667925-B2 | Transgenic plants having altered biomass composition | CERES, INC. (US) | 2023-06-06 | — | — | US | disclosed |
| US-20230167223-A1 | PROCESS FOR PREPARING OLEFIN-ACRYLATE BLOCK COPOLYMERS | DOW GLOBAL TECHNOLOGIES LLC | 2023-06-01 | — | — | US | disclosed |
| US-20230167222-A1 | PROCESS FOR PREPARING OLEFIN-ACRYLATE BLOCK COPOLYMERS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2023-06-01 | — | — | US | disclosed |
| EP-4185619-A1 | (METH)ACRYLATE FUNCTIONAL DISPERSANT | ARKEMA FRANCE (FR) | 2023-05-31 | — | — | EP | disclosed |
| US-20230159841-A1 | MACROMOLECULAR CORROSION (MCIN) INHIBITORS: STRUCTURES, METHODS OF MAKING AND USING THE SAME | POLNOX CORPORATION | 2023-05-25 | — | — | US | disclosed |
| CN-116144004-A | Heterogeneous titanium catalyst for PBAT polymerization and preparation method and application thereof | 浙江理工大学 | 2023-05-23 | — | — | CN | disclosed |
| WO-2023086499-A1 | IONIC LIQUID COMPOSITIONS | I2O THERAPEUTICS, INC. (US) | 2023-05-19 | — | — | WO | disclosed |
| CN-116113623-A | Mixtures and compositions comprising 5-fluoro-4-imino-3-methyl-1-tosyl-3, 4-dihydropyrimidin-2-one and methods of use thereof | 阿达玛马克西姆有限公司 | 2023-05-12 | — | — | CN | disclosed |
| EP-4168427-A1 | HUMAN CYTOMEGALOVIRUS GB POLYPEPTIDE | Pfizer Inc. (US) | 2023-04-26 | — | — | EP | disclosed |
| US-20230117813-A1 | PARAMETER DERIVATION IN CROSS COMPONENT MODE | BEIJING BYTEDANCE NETWORK TECHNOLOGY CO., LTD. (CN) | 2023-04-20 | — | — | US | disclosed |
| US-11629172-B2 | Human cytomegalovirus gB polypeptide | PFIZER INC. (US) | 2023-04-18 | — | — | US | disclosed |
| CN-115867585-A | (meth) acrylate functional dispersants | 阿科玛法国公司 | 2023-03-28 | — | — | CN | disclosed |
| CN-115803353-A | Method for preparing olefin-acrylate block copolymer by RAFT polymerization | 陶氏环球技术有限责任公司 | 2023-03-14 | — | — | CN | disclosed |
| EP-4143249-A1 | PROCESS FOR PREPARING OLEFIN-ACRYLATE BLOCK COPOLYMERS BY ATRP | Dow Global Technologies LLC (US) | 2023-03-08 | — | — | EP | disclosed |
| EP-4143248-A1 | PROCESS FOR PREPARING OLEFIN-ACRYLATE BLOCK COPOLYMERS BY RAFT POLYERIZATION | Dow Global Technologies LLC (US) | 2023-03-08 | — | — | EP | disclosed |
| US-11578285-B2 | Macromolecular corrosion (McIn) inhibitors: structures, methods of making and using the same | POLNOX CORPORATION (US) | 2023-02-14 | — | — | US | disclosed |
| CN-115702178-A | Process for preparing olefin-acrylate block copolymers by ATRP | 陶氏环球技术有限责任公司 | 2023-02-14 | — | — | CN | disclosed |
| US-11553194-B2 | Parameter derivation in cross component mode | BEIJING BYTEDANCE NETWORK TECHNOLOGY CO., LTD. (CN) | 2023-01-10 | — | — | US | disclosed |
| EP-3230344-B1 | METHOD FOR THE PREPARATION OF POLYASPARTIC ACID BY MEANS OF PRE-CONDENSATE | BASF SE (DE) | 2023-01-04 | — | — | EP | disclosed |
| EP-3389622-B1 | OXIDIZING COMPOSITION FOR TREATING KERATIN MATERIALS, COMPRISING A FATTY SUBSTANCE AND OXYALKYLENATED SURFACTANTS | OREAL (FR) | 2023-01-04 | — | — | EP | disclosed |
| WO-2022268943-A1 | COATED GRANULAR SUBSTANCE, METHOD FOR COATING A GRANULAR SUBSTANCE AND USE OF A BINDER FOR COATING A GRANULAR SUBSTANCE | ASK CHEMICALS GMBH (DE) | 2022-12-29 | — | — | WO | disclosed |
| WO-2022258494-A1 | HAIR DYEING PROCESS COMPRISING THE APPLICATION OF A (POLY)CARBODIIMIDE COMPOUND, OF A POLYMER BEARING A CARBOXYLIC GROUP AND OF A NON-SILICONE FATTY SUBSTANCE | L'OREAL (FR) | 2022-12-15 | — | — | WO | disclosed |
| WO-2022259211-A1 | OPHTHALMIC COMPOSITIONS AND/OR METHODS FOR PRESBYOPIA, MYDRIASIS AND/OR OCULAR DISCOMFORT MANAGEMENT | BRIEN HOLDEN VISION INSTITUTE LIMITED (AU) | 2022-12-15 | — | — | WO | disclosed |
| CN-113692741-B | Parameter derivation in cross-component mode | 北京字节跳动网络技术有限公司 | 2022-12-13 | — | — | CN | disclosed |
| US-11510861-B2 | Hair treatment process using a composition comprising at least one cationic acrylic copolymer | L'OREAL (FR) | 2022-11-29 | — | — | US | disclosed |
| EP-3347405-B1 | METHOD FOR THE PREPARATION OF POLYASPARTIC ACID UNDER REFLUX | BASF SE (DE) | 2022-11-09 | — | — | EP | disclosed |
| WO-2022232566-A2 | COLLAGEN COMPOSITIONS AND METHODS OF USE THEREOF | MODERN MEADOW, INC. (US) | 2022-11-03 | — | — | WO | disclosed |
| WO-2022229557-A1 | OIL-IN-WATER COSMETIC COMPOSITION COMPRISING PIGMENTS | LABORATOIRES CLARINS (FR) | 2022-11-03 | — | — | WO | disclosed |
| WO-2022225838-A1 | MOLECULES WITH ENGINEERED ANTIBODY CONSTANT REGION VARIANTS | JANSSEN BIOTECH, INC. (US) | 2022-10-27 | — | — | WO | disclosed |
| EP-4076360-A1 | COMPOSITION COMPRISING A SOLUBILIZED SOLID FATTY ALCOHOL AND A MONOALCOHOL | L'OREAL (FR) | 2022-10-26 | — | — | EP | disclosed |
| CN-217656637-U | Home gateway with voice control function | 无锡市电子仪表工业有限公司 | 2022-10-25 | — | — | CN | disclosed |
| EP-4068963-A1 | COMPOSITION CONTAINING 4-(3-ETHOXY-4-HYDROXYPHENYL)BUTAN-2-ONE, A PRESERVATIVE AND/OR ANTIOXIDANT, A SURFACTANT AND A POLYMER, AND THE METHOD FOR PROCESSING KERATIN MATERIALS FROM THE COMPOSITION | L'OREAL (FR) | 2022-10-12 | — | — | EP | disclosed |
| CN-115175656-A | Cosmetic composition in the form of a W/O emulsion comprising a spherical hydrophobic silica aerogel and an ester oil | 莱雅公司 | 2022-10-11 | — | — | CN | disclosed |
| US-11464888-B2 | Moldable formulations containing an oxysterol in an acellular tissue matrix | WARSAW ORTHOPEDIC, INC. (US) | 2022-10-11 | — | — | US | disclosed |
| WO-2022207692-A1 | METHODS FOR PRODUCING OPTICAL EFFECT LAYERS COMPRISING MAGNETIC OR MAGNETIZABLE PIGMENT PARTICLES AND EXHIBITING ONE OR MORE INDICIA | SICPA HOLDING SA (CH) | 2022-10-06 | — | — | WO | disclosed |
| US-11463714-B2 | Selective use of cross component mode in video coding | BEIJING BYTEDANCE NETWORK TECHNOLOGY CO., LTD. (CN) | 2022-10-04 | — | — | US | disclosed |
| WO-2022195214-A1 | TOPICAL PHARMACEUTICAL COMPOSITION COMPRISING AMITRIPTYLINE AND AN ALKALINE AQUEOUS PHASE | ALGOTHERAPEUTIX (FR) | 2022-09-22 | — | — | WO | disclosed |
| US-11446222-B2 | Composition for treating keratin fibers comprising an amphoteric or cationic polymer and neutralized fatty acid | L'OREAL (FR) | 2022-09-20 | — | — | US | disclosed |
| US-20220282274-A1 | TRANSGENIC PLANTS HAVING ALTERED BIOMASS COMPOSITION | CERES INC (US) | 2022-09-08 | — | — | US | disclosed |
| EP-3617217-B1 | PROCESS FOR THE PRODUCTION OF OXYSTEROLS | WARSAW ORTHOPEDIC INC (US) | 2022-09-07 | — | — | EP | disclosed |
| US-20220261634-A1 | NEURAL NETWORK QUANTIZATION PARAMETER DETERMINATION METHOD AND RELATED PRODUCTS | SHANGHAI CAMBRICON INFORMATION TECHNOLOGY CO., LTD (CN) | 2022-08-18 | — | — | US | disclosed |
| CN-114901073-A | Fungicidal combinations, mixtures and compositions and their use | 阿达马蒂斯有限公司 | 2022-08-12 | — | — | CN | disclosed |
| US-20220248673-A1 | FUNGICIDAL COMBINATIONS, MIXTURES AND COMPOSITIONS AND USES THEREOF | ADAMA MAKHTESHIM LTD. (IL) | 2022-08-11 | — | — | US | disclosed |
| WO-2022170114-A1 | SKINCARE COMPOSITIONS AND METHODS OF USE THEREOF | MODERN MEADOW, INC. (US) | 2022-08-11 | — | — | WO | disclosed |
| US-20220242591-A1 | SYSTEMS AND METHODS FOR ASSEMBLING CONTAINERIZED AIRCRAFT | THE BOEING COMPANY | 2022-08-04 | — | — | US | disclosed |
| WO-2022162591-A1 | 5-FLUORO-4-IMINO-3-METHYL-1-TOSYL-3,4-DIHYDROPYRIMIDIN-2(1 H)-ONE FOR CONTROLLING PLANT DISEASES | ADAMA MAKHTESHIM LTD. (IL) | 2022-08-04 | — | — | WO | disclosed |
| US-20220229049-A1 | REAGENTS FOR SANDWICH IMMUNOASSAYS USING PARTICLE ENHANCED AGGLUTINATION DETECTION AND METHODS OF PRODUCTION AND USE THEREOF | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2022-07-21 | — | — | US | disclosed |
| US-11382849-B2 | Non-dyeing composition comprising a cationic acrylic copolymer and a conditioning agent | L'OREAL (FR) | 2022-07-12 | — | — | US | disclosed |
| US-11384114-B2 | Polymorphic forms of an oxysterol and methods of making them | WARSAW ORTHOPEDIC, INC. (US) | 2022-07-12 | — | — | US | disclosed |
| CN-112094663-B | Method and device for separating Fischer-Tropsch synthesis product | 国家能源集团宁夏煤业有限责任公司 | 2022-07-01 | — | — | CN | disclosed |
| US-20220193029-A1 | BRYOSTATIN COMPOUNDS FOR ENHANCEMENT OF IMMUNOTHERAPY | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2022-06-23 | — | — | US | disclosed |
| WO-2022129602-A1 | AEROSOL DEVICE CONTAINING A COMPOSITION COMPRISING A SOLID FATTY ALCOHOL AND A LIQUEFIED GAS | L'OREAL (FR) | 2022-06-23 | — | — | WO | disclosed |
| WO-2022129358-A1 | AEROSOL DEVICE CONTAINING A COMPOSITION COMPRISING A SOLID FATTY ALCOHOL, A MONOALCOHOL AND A COMPRESSED GAS | L'OREAL (FR) | 2022-06-23 | — | — | WO | disclosed |
| WO-2022133232-A1 | METHODS FOR MANUFACTURE OF SMALL MOLECULE ACTIVATORS OF TIE-2 | EyePoint Pharmaceuticals, Inc. (US) | 2022-06-23 | — | — | WO | disclosed |
| CN-114637129-A | Devices, systems, and/or methods for myopia control | 华柏恩视觉研究中心有限公司 | 2022-06-17 | — | — | CN | disclosed |
| US-20220177415-A1 | QUATERNARY FATTY AMIDOAMINE DETERGENTS | NOURYON CHEMICALS INTERNATIONAL B.V. (NL) | 2022-06-09 | — | — | US | disclosed |
| US-11352149-B2 | Systems and methods for assembling containerized aircraft | THE BOEING COMPANY (US) | 2022-06-07 | — | — | US | disclosed |
| EP-4003017-A1 | FUNGICIDAL COMBINATIONS, MIXTURES AND COMPOSITIONS AND USES THEREOF | Adama Makhteshim Ltd. (IL) | 2022-06-01 | — | — | EP | disclosed |
| CN-111094459-B | Aqueous polymer composition | 陶氏环球技术有限责任公司 | 2022-05-27 | — | — | CN | disclosed |
| US-20220152100-A1 | METHODS FOR CONTROLLED ACTIVATION OR ELIMINATION OF THERAPEUTIC CELLS | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | 2022-05-19 | — | — | US | disclosed |
| US-20220151827-A1 | Ophthalmic Compositions, and Ocular Uses Thereof, of Indigo Carmine | ZEBRA BIOTECH PTY LTD (AU) | 2022-05-19 | — | — | US | disclosed |
| EP-3998554-A1 | METHOD FOR DETERMINING QUANTIZATION PARAMETER OF NEURAL NETWORK, AND RELATED PRODUCT | Shanghai Cambricon Information Technology Co., Ltd (CN) | 2022-05-18 | — | — | EP | disclosed |
| US-11324759-B2 | Oxysterol-statin compounds for bone growth | WARSAW ORTHOPEDIC, INC. (US) | 2022-05-10 | — | — | US | disclosed |
| EP-3990923-A1 | REAGENTS FOR SANDWICH IMMUNOASSAYS USING PARTICLE ENHANCED AGGLUTINATION DETECTION AND METHODS OF PRODUCTION AND USE THEREOF | Siemens Healthcare Diagnostics, Inc. (US) | 2022-05-04 | — | — | EP | disclosed |
| WO-2022084206-A1 | REDUCING POWER CONSUMPTION FOR DEVICE-TO-DEVICE COMMUNICATION | Sony Group Corporation (JP) | 2022-04-28 | — | — | WO | disclosed |
| EP-3323437-B1 | LYOPHILIZED MOLDABLE IMPLANTS CONTAINING AN OXYSTEROL | WARSAW ORTHOPEDIC INC (US) | 2022-04-27 | — | — | EP | disclosed |
| US-11299571-B2 | Aqueous polymer composition | DOW GLOBAL TECHNOLOGIES, LLC (US) | 2022-04-12 | — | — | US | disclosed |
| US-11299747-B2 | Transgenic plants having altered biomass composition | CERES, INC. (US) | 2022-04-12 | — | — | US | disclosed |
| EP-3972585-A1 | BRYOSTATIN COMPOUNDS FOR ENHANCEMENT OF IMMUNOTHERAPY | The Board Of Trustees Of The Leland Stanford Junior University (US) | 2022-03-30 | — | — | EP | disclosed |
| US-20220088184-A1 | HUMAN CYTOMEGALOVIRUS GB POLYPEPTIDE | PFIZER INC. | 2022-03-24 | — | — | US | disclosed |
| EP-3367973-B1 | IMPLANTS HAVING A DRUG LOAD OF AN OXYSTEROL AND METHODS OF USE | WARSAW ORTHOPEDIC INC (US) | 2022-03-23 | — | — | EP | disclosed |
| CN-110546217-B | Aqueous polymer dispersion and aqueous coating composition comprising the same | 陶氏环球技术有限责任公司 | 2022-03-22 | — | — | CN | disclosed |
| US-20220082697-A1 | LASER RADAR | NIKON METROLOGY NV (BE) | 2022-03-17 | — | — | US | disclosed |
| CN-114173724-A | Ophthalmic compositions of indigo carmine and ophthalmic uses thereof | 米纳斯·希欧多尔·科罗内奥 | 2022-03-11 | — | — | CN | disclosed |
| CN-114174530-A | Methods and compositions for analyzing nucleic acids | 克拉雷特生物科学有限责任公司 | 2022-03-11 | — | — | CN | disclosed |
| CN-108079374-B | Freeze-dried moldable implant containing oxysterol | 华沙整形外科股份有限公司 | 2022-03-04 | — | — | CN | disclosed |
| CN-109010916-B | Moldable formulations containing oxysterol in acellular tissue matrices | 华沙整形外科股份有限公司 | 2022-03-04 | — | — | CN | disclosed |
| WO-2022043855-A1 | GROUP B STREPTOCOCCUS POLYSACCHARIDE-PROTEIN CONJUGATES, METHODS FOR PRODUCING CONJUGATES, IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATES, AND USES THEREOF | PFIZER INC. (US) | 2022-03-03 | — | — | WO | disclosed |
| US-11260006-B2 | Cosmetic composition comprising an anionic surfactant, at least 3.5% by weight of a fatty acid and an antidandruff agent | L'OREAL (FR) | 2022-03-01 | — | — | US | disclosed |
| US-11246814-B2 | Oxidizing composition for treating keratin materials, comprising a fatty substance and oxyalkylenated surfactants | L'OREAL (FR) | 2022-02-15 | — | — | US | disclosed |
| US-11246824-B2 | Cosmetic composition comprising a particular combination of surfactants, a silicone, a cationic polymer, a fatty alcohol and a clay | L'OREAL (FR) | 2022-02-15 | — | — | US | disclosed |
| CN-110226118-B | Devices, systems, and/or methods for myopia control | 华柏恩视觉研究中心有限公司 | 2022-02-11 | — | — | CN | disclosed |
| US-20220040058-A1 | COSMETIC HAIR COMPOSITION IN THE FORM OF A NANOEMULSION COMPRISING A PARTICULAR NON-IONIC SURFACTANT AND A PROPELLANT | L'OREAL (FR) | 2022-02-10 | — | — | US | disclosed |
| WO-2022026085-A1 | GEL COMPOSITIONS COMPRISING HYDROPHOBIC SILICA AND A COPOLYMER FORMED FROM SULFONIC ACID ACRYLIC MONOMER | L'OREAL (FR) | 2022-02-03 | — | — | WO | disclosed |
| CN-114008457-A | Sandwich immunoassay reagents using particle-enhanced agglutination assays and methods of making and using same | 美国西门子医学诊断股份有限公司 | 2022-02-01 | — | — | CN | disclosed |
| US-20220024946-A1 | BINDING COMPETITORS FOR USE IN MACROPHILIN-BINDING PHARMACEUTICAL ASSAYS AND METHODS OF USE THEREOF | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2022-01-27 | — | — | US | disclosed |
| US-20220024946-A1 | BINDING COMPETITORS FOR USE IN MACROPHILIN-BINDING PHARMACEUTICAL ASSAYS AND METHODS OF USE THEREOF | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2022-01-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (50 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12171909-B2 | Implants having a drug load of an oxysterol and methods of use | SOST, CYP17A1, HSD17B7 | MAPK8 4010/4885MAPK9 3622/4885MAPK10 2281/4885 |
| US-11578285-B2 | Macromolecular corrosion (McIn) inhibitors: structures, methods of making and using the same | MB, NCLN, CPN1 | MAPK8 2699/4885MAPK9 1258/4885MAPK10 1557/4885 |
| US-20240208996-A1 | BINDING COMPETITORS FOR USE IN MACROPHILIN-BINDING PHARMACEUTICAL ASSAYS AND METHODS OF USE THEREOF | CD14, CD68, MYADM | MAPK8 4036/4885MAPK9 4390/4885MAPK10 4069/4885 |
| US-20250366468-A1 | MIXTURES AND COMPOSITIONS COMPRISING 5-FLUORO-4-IMINO-3-METHYL-1-TOSYL-3,4-DIHYDROPYRIMIDIN-2-ONE, AND METHODS OF USE THEREOF | FFAR3, FFAR1, FFAR4 | MAPK8 3166/4885MAPK9 2795/4885MAPK10 3242/4885 |
| US-20260108554-A1 | METHODS FOR REPROGRAMMING AND GENE EDITING CELLS | B2M, MYADM, CD74 | MAPK8 4324/4885MAPK9 4054/4885MAPK10 4517/4885 |
| US-11746105-B2 | Bryostatin compounds and methods of preparing the same | PROKR1, PBK, PROKR2 | MAPK8 1617/4885MAPK9 1925/4885MAPK10 1337/4885 |
| US-20240190857-A1 | METHODS FOR MANUFACTURE OF SMALL MOLECULE ACTIVATORS OF TIE-2 | TIE1, TEK, KDR | MAPK8 1568/4885MAPK9 2080/4885MAPK10 2485/4885 |
| US-12447207-B2 | Human cytomegalovirus gB polypeptide | GBA3, HBB, PDGFA | MAPK8 2966/4885MAPK9 2230/4885MAPK10 3611/4885 |
| US-12077486-B2 | Quaternary fatty amidoamine detergents | ACMSD, ABHD5, ABHD6 | MAPK8 2872/4885MAPK9 1526/4885MAPK10 2388/4885 |
| US-20220024946-A1 | BINDING COMPETITORS FOR USE IN MACROPHILIN-BINDING PHARMACEUTICAL ASSAYS AND METHODS OF USE THEREOF | CD68, CD14, MYADM | MAPK8 4532/4885MAPK9 4521/4885MAPK10 4334/4885 |
| US-20260037299-A1 | CLUSTER INSTRUCTIONS | NCL, HNRNPU, NOP56 | MAPK8 1403/4885MAPK9 1398/4885MAPK10 1848/4885 |
| US-11324759-B2 | Oxysterol-statin compounds for bone growth | HMGCR, SOST, OSBP2 | MAPK8 3523/4885MAPK9 3066/4885MAPK10 2345/4885 |
| US-20220040058-A1 | COSMETIC HAIR COMPOSITION IN THE FORM OF A NANOEMULSION COMPRISING A PARTICULAR NON-IONIC SURFACTANT AND A PROPELLANT | KRT18, POLR1C, FSCN1 | MAPK8 2398/4885MAPK9 1852/4885MAPK10 1531/4885 |
| US-11446222-B2 | Composition for treating keratin fibers comprising an amphoteric or cationic polymer and neutralized fatty acid | KRT18, DSG1, FABP4 | MAPK8 2294/4885MAPK9 1941/4885MAPK10 628/4885 |
| US-11629172-B2 | Human cytomegalovirus gB polypeptide | GBA3, HBB, PDGFA | MAPK8 2871/4885MAPK9 2770/4885MAPK10 3826/4885 |
| US-20260146138-A1 | METHODS OF RECYCLING POLYVINYL BUTYRAL | AGL, VMP1, FTO | MAPK8 4025/4885MAPK9 3814/4885MAPK10 4138/4885 |
| US-20240100153-A1 | HUMAN CYTOMEGALOVIRUS GB POLYPEPTIDE | GBA3, HBB, PDGFA | MAPK8 2888/4885MAPK9 2747/4885MAPK10 3834/4885 |
| US-20260037301-A1 | COMPUTE SYSTEM | APOBEC3B, FURIN, TSN | MAPK8 2601/4885MAPK9 3264/4885MAPK10 3633/4885 |
| US-11246814-B2 | Oxidizing composition for treating keratin materials, comprising a fatty substance and oxyalkylenated surfactants | KRT18, OAT, PLOD3 | MAPK8 3831/4885MAPK9 3309/4885MAPK10 1618/4885 |
| US-20230321212-A1 | GROUP B STREPTOCOCCUS POLYSACCHARIDE-PROTEIN CONJUGATES, METHODS FOR PRODUCING CONJUGATES, IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATES, AND USES THEREOF | SIGLEC7, SIGLEC9, FCGR3B | MAPK8 4587/4885MAPK9 3116/4885MAPK10 4288/4885 |
| US-12600810-B2 | Process for preparing olefin-acrylate block copolymers | CBR1, CBR3, CLTB | MAPK8 3507/4885MAPK9 3289/4885MAPK10 2341/4885 |
| US-12599181-B2 | Moisture lock fluid retention assemblies, garments including the same, and related methods | WAPL, AQP4, DSG1 | MAPK8 3507/4885MAPK9 3980/4885MAPK10 4330/4885 |
| US-20220177415-A1 | QUATERNARY FATTY AMIDOAMINE DETERGENTS | ACMSD, ABHD5, ABHD6 | MAPK8 2872/4885MAPK9 1526/4885MAPK10 2388/4885 |
| US-20250176549-A1 | FUNGICIDAL COMBINATIONS, MIXTURES AND COMPOSITIONS AND USES THEREOF | THRB, OSBP, TPI1 | MAPK8 881/4885MAPK9 2269/4885MAPK10 1805/4885 |
| US-20240237649-A1 | CRYSTALLINE FORMS OF 5-FLUORO-4-IMINO-3-METHYL-1-TOSYL-3,4-DIHYDROPYRIMIDIN-2-ONE, AND MIXTURES, COMPOSITIONS AND METHODS OF USE THEREOF | NT5C, RCC1, INF2 | MAPK8 4476/4885MAPK9 4083/4885MAPK10 4752/4885 |
| US-11384114-B2 | Polymorphic forms of an oxysterol and methods of making them | HSD3B1, VKORC1L1, VKORC1 | MAPK8 4706/4885MAPK9 4646/4885MAPK10 4232/4885 |
| US-20260050068-A1 | GLARE-RESISTANT LIDAR | LBR, CASR, TRPC6 | MAPK8 772/4885MAPK9 1583/4885MAPK10 1186/4885 |
| US-11260006-B2 | Cosmetic composition comprising an anionic surfactant, at least 3.5% by weight of a fatty acid and an antidandruff agent | CUTA, SMURF1, PLIN5 | MAPK8 4455/4885MAPK9 3139/4885MAPK10 2358/4885 |
| US-20260037300-A1 | COMPUTE TILES | TSN, NCL, TCP1 | MAPK8 1902/4885MAPK9 1976/4885MAPK10 1705/4885 |
| US-20240390258-A1 | FOAMING COMPOSITION | SGMS1, SGMS2, SMURF1 | MAPK8 4635/4885MAPK9 4723/4885MAPK10 4210/4885 |
| US-12492352-B2 | Macromolecular corrosion (MCIN) inhibitors: structures, methods of making and using the same | MB, NCLN, CPN1 | MAPK8 2699/4885MAPK9 1258/4885MAPK10 1557/4885 |
| US-12584142-B2 | Transgenic plants having altered biomass composition | OSGEP, RNGTT, PHAX | MAPK8 740/4885MAPK9 691/4885MAPK10 2117/4885 |
| US-12508707-B2 | Control devices for end effectors with multi-axis roller wheels, systems including the same, and related methods | TOE1, GNRHR, ELMO1 | MAPK8 795/4885MAPK9 2168/4885MAPK10 2129/4885 |
| US-12151016-B2 | Hair shaping process using a composition comprising at least one silicone acrylic copolymer | KRT18, MATR3, ACR | MAPK8 1595/4885MAPK9 1016/4885MAPK10 927/4885 |
| US-20250143981-A1 | AEROSOL DEVICE CONTAINING A COMPOSITION COMPRISING A BRANCHED ALKANE, A FATTY SUBSTANCE AND A PROPELLANT | FFAR3, ALK, C3AR1 | MAPK8 4412/4885MAPK9 4712/4885MAPK10 4054/4885 |
| US-20260042995-A1 | ISOLATING AND LYSING CELLS | CLPP, DNASE1, MMP1 | MAPK8 1311/4885MAPK9 1936/4885MAPK10 1063/4885 |
| US-20220193029-A1 | BRYOSTATIN COMPOUNDS FOR ENHANCEMENT OF IMMUNOTHERAPY | CD69, PBK, KLRK1 | MAPK8 2683/4885MAPK9 3747/4885MAPK10 1509/4885 |
| US-20230292746-A1 | MIXTURES AND COMPOSITIONS COMPRISING 5-FLUORO-4-IMINO-3- METHYL-1-TOSYL-3,4-DIHYDROPYRIMIDIN-2-ONE, AND METHODS OF USE THEREOF | CYP3A5, CYP4B1, CYP51A1 | MAPK8 3348/4885MAPK9 2418/4885MAPK10 3957/4885 |
| US-20260037270-A1 | HOST INSTRUCTIONS | SET, CPSF1, PLAU | MAPK8 3636/4885MAPK9 4290/4885MAPK10 3991/4885 |
| US-20260103652-A1 | MACROMOLECULAR CORROSION (McIn) INHIBITORS: STRUCTURES, METHODS OF MAKING AND USING THE SAME | MPO, CYC1, CBR1 | MAPK8 2405/4885MAPK9 1707/4885MAPK10 1641/4885 |
| US-11382849-B2 | Non-dyeing composition comprising a cationic acrylic copolymer and a conditioning agent | MSR1, ARG1, CD47 | MAPK8 3295/4885MAPK9 2869/4885MAPK10 884/4885 |
| US-11510861-B2 | Hair treatment process using a composition comprising at least one cationic acrylic copolymer | KRT18, ACR, NUP205 | MAPK8 2016/4885MAPK9 1379/4885MAPK10 1174/4885 |
| US-20240116908-A1 | BRYOSTATIN COMPOUNDS AND METHODS OF PREPARING THE SAME | PROKR1, PBK, PROKR2 | MAPK8 1617/4885MAPK9 1925/4885MAPK10 1337/4885 |
| US-20240172750-A1 | 5-Fluoro-4-Imino-3-Methyl-1-Tosyl-3,4-Dihydropyrimidin-2(1H)-One for Controlling Plant Diseases | DPM1, INMT, NPM1 | MAPK8 3444/4885MAPK9 2665/4885MAPK10 3668/4885 |
| US-12534562-B2 | Process for preparing olefin-acrylate block copolymers by ATRP | ATR, ATRIP, TRRAP | MAPK8 3427/4885MAPK9 2392/4885MAPK10 713/4885 |
| US-20220088184-A1 | HUMAN CYTOMEGALOVIRUS GB POLYPEPTIDE | GBA3, HBB, PDGFA | MAPK8 2888/4885MAPK9 2747/4885MAPK10 3834/4885 |
| US-12414559-B2 | Mixtures and compositions comprising 5-fluoro-4-imino-3-methyl-1-tosyl-3,4-dihydropyrimidin-2-one, and methods of use thereof | FFAR3, FFAR1, FFAR4 | MAPK8 3178/4885MAPK9 2798/4885MAPK10 3250/4885 |
| US-20220248673-A1 | FUNGICIDAL COMBINATIONS, MIXTURES AND COMPOSITIONS AND USES THEREOF | CYP3A43, CYP2F1, CYP4F11 | MAPK8 4679/4885MAPK9 3327/4885MAPK10 4752/4885 |
| US-20250338845-A1 | FUNGICIDAL COMBINATIONS, MIXTURES AND COMPOSITIONS AND USES THEREOF | SDHA, SDHB, SQOR | MAPK8 4539/4885MAPK9 3376/4885MAPK10 4763/4885 |
| US-11958863-B2 | Binding competitors for use in macrophilin-binding pharmaceutical assays and methods of use thereof | CD14, CD68, MYADM | MAPK8 4036/4885MAPK9 4390/4885MAPK10 4069/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.